Guidance and Best Practice

The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs. 

We have guidelines on asthma from two different sources in the UK – BTS/SIGN and NICE. The British Asthma guideline from BTS/SIGN was first published in 2003 and is well established, respected and comprehensive. NICE decided to develop first a guideline on diagnosis and monitoring in asthma, and then a guideline on asthma management, and they finally came together in a single published guideline in November 2017. 

Briefing document for National Respiratory Strategies – the NHS Long term plan and Lung Health Taskforce 5 year plan.

This is the most recent briefing paper on the latest update to the BTS/SIGN British Asthma Guideline.

In this regular PCRU feature we explore cases of rarer lung conditions and their presentation. In this short case discussion Fran Robinson interviews Dr Stephen Gaduzo as they discuss John, an amateur footballer who has recently been diagnosed with asthma. Originally published in the Winter 2018 edition of the Primary Care Respiratory Update.

Monitoring ICS underuse in asthma and over-reliance on SABA: A sponsored supplement. Improving outcomes in asthma as an inflammatory disease: spotlight on monitoring ICS underuse and over-reliance on SABA: A sponsored supplement. A report of a multi-disciplinary consensus meeting held in December 2018. AstraZeneca organised and fully funded the meeting and the production of this supplement. All meeting participants reviewed and commented upon the content of this supplement. The views expressed are not necessarily those of AstraZeneca or PCRS.

The asthma slide rule helps to start a conversation with your patients and/or colleagues around how much salbutamol is acceptable before a review is necessary